Advertisement

Triplet-Repeat Primed PCR and Capillary Electrophoresis for Characterizing the Fragile X Mental Retardation 1 CGG Repeat Hyperexpansions

  • Indhu-Shree Rajan-Babu
  • Samuel S. ChongEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1972)

Abstract

Fragile X mental retardation 1 (FMR1) CGG repeat expansions cause fragile X syndrome—the leading monogenic form of intellectual disability—and increase the risk for fragile X-associated tremor ataxia syndrome and fragile X-associated primary ovarian insufficiency. Southern blot (SB) analysis is the current gold standard test for FMR1 molecular diagnosis. Several polymerase chain reaction (PCR)-based methods are now available for sizing FMR1 CGG repeat expansions. These methods offer higher diagnostic sensitivity and specificity compared to SB analysis, significantly reduce the turnaround time and increase throughput. In this chapter, we describe a triplet-repeat primed PCR protocol that employs capillary electrophoresis to resolve the derived amplicon products, enabling precise determination of the FMR1 genotypes in both males and females and characterization of the CGG repeat structure.

Key words

Capillary electrophoresis TP-PCR FMR1 Fragile X syndrome Repeat expansion FXTAS FXPOI 

References

  1. 1.
    Yu TW, Berry-Kravis E (2014) Autism and fragile X syndrome. Semin Neurol 34:258–265CrossRefGoogle Scholar
  2. 2.
    Hill MK, Archibald AD, Cohen J, Metcalfe SA (2010) A systematic review of population screening for fragile X syndrome. Genet Med 12:396–410CrossRefGoogle Scholar
  3. 3.
    Monaghan KG, Lyon E, Spector EB, erican College of Medical G, Genomics (2013) ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics. Genet Med 15:575–586CrossRefGoogle Scholar
  4. 4.
    Saul RA, Tarleton JC (1993) FMR1-related disorders. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, LJH B, Stephens K, Amemiya A (eds) GeneReviews®. University of Washington, Seattle, WAGoogle Scholar
  5. 5.
    Usdin K, Hayward BE, Kumari D, Lokanga RA, Sciascia N, Zhao XN (2014) Repeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disorders. Front Genet 5:226CrossRefGoogle Scholar
  6. 6.
    Willemsen R, Levenga J, Oostra BA (2011) CGG repeat in the FMR1 gene: size matters. Clin Genet 80:214–225CrossRefGoogle Scholar
  7. 7.
    Tassone F et al (2012) FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med 4:100CrossRefGoogle Scholar
  8. 8.
    Maenner MJ et al (2013) FMR1 CGG expansions: prevalence and sex ratios. Am J Med Genet B Neuropsychiatr Genet 162B:466–473CrossRefGoogle Scholar
  9. 9.
    Seltzer MM, Baker MW, Hong J, Maenner M, Greenberg J, Mandel D (2012) Prevalence of CGG expansions of the FMR1 gene in a US population-based sample. Am J Med Genet B Neuropsychiatr Genet 159B:589–597CrossRefGoogle Scholar
  10. 10.
    Jin P, Warren ST (2000) Understanding the molecular basis of fragile X syndrome. Hum Mol Genet 9:901–908CrossRefGoogle Scholar
  11. 11.
    Nolin SL et al (2003) Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet 72:454–464CrossRefGoogle Scholar
  12. 12.
    Yrigollen CM, Durbin-Johnson B, Gane L, Nelson DL, Hagerman R, Hagerman PJ, Tassone F (2012) AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genet Med 14:729–736CrossRefGoogle Scholar
  13. 13.
    Fernandez-Carvajal I, Lopez Posadas B, Pan R, Raske C, Hagerman PJ, Tassone F (2009) Expansion of an FMR1 grey-zone allele to a full mutation in two generations. J Mol Diagn 11:306–310CrossRefGoogle Scholar
  14. 14.
    Tassone F (2015) Advanced technologies for the molecular diagnosis of fragile X syndrome. Expert Rev Mol Diagn 15:1465–1473CrossRefGoogle Scholar
  15. 15.
    Nolin SL, Glicksman A, Ding X, Ersalesi N, Brown WT, Sherman SL, Dobkin C (2011) Fragile X analysis of 1112 prenatal samples from 1991 to 2010. Prenat Diagn 31:925–931CrossRefGoogle Scholar
  16. 16.
    Nolin SL et al (2013) Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles. Am J Med Genet A 161A:771–778CrossRefGoogle Scholar
  17. 17.
    Chen L et al (2010) An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis. J Mol Diagn 12:589–600CrossRefGoogle Scholar
  18. 18.
    Chen L et al (2011) High-resolution methylation polymerase chain reaction for fragile X analysis: evidence for novel FMR1 methylation patterns undetected in Southern blot analyses. Genet Med 13:528–538CrossRefGoogle Scholar
  19. 19.
    Filipovic-Sadic S et al (2010) A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clin Chem 56:399–408PubMedPubMedCentralGoogle Scholar
  20. 20.
    Hantash FM et al (2010) Qualitative assessment of FMR1 (CGG)n triplet repeat status in normal, intermediate, premutation, full mutation, and mosaic carriers in both sexes: implications for fragile X syndrome carrier and newborn screening. Genet Med 12:162–173CrossRefGoogle Scholar
  21. 21.
    Rajan-Babu IS, Law HY, Yoon CS, Lee CG, Chong SS (2015) Simplified strategy for rapid first-line screening of fragile X syndrome: closed-tube triplet-primed PCR and amplicon melt peak analysis. Expert Rev Mol Med 17:e7CrossRefGoogle Scholar
  22. 22.
    Rajan-Babu IS, Teo CR, Lian M, Lee CG, Law HY, Chong SS (2015) Single-tube methylation-specific duplex-PCR assay for rapid and accurate diagnosis of Fragile X Mental Retardation 1-related disorders. Expert Rev Mol Diagn 15:431–441CrossRefGoogle Scholar
  23. 23.
    Zhou Y, Law HY, Boehm CD, Yoon CS, Cutting GR, Ng IS, Chong SS (2004) Robust fragile X (CGG)n genotype classification using a methylation specific triple PCR assay. J Med Genet 41:e45CrossRefGoogle Scholar
  24. 24.
    Zhou Y, Lum JM, Yeo GH, Kiing J, Tay SK, Chong SS (2006) Simplified molecular diagnosis of fragile X syndrome by fluorescent methylation-specific PCR and GeneScan analysis. Clin Chem 52:1492–1500CrossRefGoogle Scholar
  25. 25.
    Rajan-Babu IS, Chong SS (2016) Molecular correlates and recent advancements in the diagnosis and screening of FMR1-related disorders. Genes (Basel) 7(10):87CrossRefGoogle Scholar
  26. 26.
    Warner JP, Barron LH, Goudie D, Kelly K, Dow D, Fitzpatrick DR, Brock DJ (1996) A general method for the detection of large CAG repeat expansions by fluorescent PCR. J Med Genet 33:1022–1026CrossRefGoogle Scholar
  27. 27.
    Lyon E, Laver T, Yu P, Jama M, Young K, Zoccoli M, Marlowe N (2010) A simple, high-throughput assay for Fragile X expanded alleles using triple repeat primed PCR and capillary electrophoresis. J Mol Diagn 12:505–511CrossRefGoogle Scholar
  28. 28.
    Fu YH et al (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67:1047–1058CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Pediatrics, Yong Loo Lin School of MedicineNational University of SingaporeSingaporeSingapore
  2. 2.Department of Medical GeneticsThe University of British ColumbiaVancouverCanada
  3. 3.Khoo Teck Puat—National University Children’s Medical InstituteNational University Health SystemSingaporeSingapore
  4. 4.Department of Laboratory MedicineNational University HospitalSingaporeSingapore

Personalised recommendations